PSYCHEDELIC-ASSISTED THERAPY FOR YOUTH AND WHAT WE KNOW FROM ADULT STUDIES

Abstract

Psychedelic-assisted therapy has garnered national media coverage over the last several years and is touting significant benefits for adult mental health. Part of the Phase III clinical trials, however, will be soliciting adolescents as participants in this alternative therapy. An overview of the research in psychedelic-assisted therapy and what this would look like for adolescents will keep school psychologists informed on this potential treatment for youth who struggle with a variety of mental health concerns.

Keywords: Social-emotional intervention, PTSD, depression, anxiety.

REFERENCES  

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof- of-concept study. Journal of Psychopharmacology, 29(3), 289–299.

Brown, H. (2021). Is psychedelic-assisted therapy effective? 6 research findings. Positive psychology.com. https://positivepsychology.com/psychedelic-assisted-therapy/  

Carhart-Harris RL, Bolstridge M, Rucker J, et al. (2016) Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry, 619–627

Center for Disease Control (2021). Data and statistics on children’s mental health. Retrieved September 10, 2021, from https://www.cdc.gov/childrensmentalhealth/data.html#ref  

Cherry, K. (2020, July 25). The importance of cognition in determining who we are. Verywell Mind. Retrieved September 9, 2021, from https://www.verywellmind.com/what-is cognition-2794982.

Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine Assisted Psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. Journal of Psychoactive Drugs, 51(2), 189-198.

Feduccia, A., A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2019). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in psychiatry, 10, 650. https://doi.org/10.3389/fpsyt.2019.00650  

Frood, A. (2012). MDMA keeps severe stress at bay. Nature. doi:10.1038/nature.2012.11864  

Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. The Journal of nervous and mental disease, 202(7), 513–520.

Hill, S. L., & Thomas, S. H. (2011). Clinical toxicology of newer recreational drugs. Clinical Toxicology, 49, 705–719.

Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 142, 143–166.

Lewis, C. C., Simons, A. D., Nguyen, L. J., Murakami, J. L., Reid, M. W., Silval, S. G. & March J. S. (2010). The Impact of childhood trauma on treatment outcome in the Treatment for 17

Adolescents with Depression Study (TADS). Journal of American Academy of Child and Adolescent Psychiatry. 49(2):132-40.

Luoma, J. B., Chwyl, C., Bathje, G. J., Davis, A. K., & Lancelotta, R. (2020). A meta-analysis of placebo- controlled trials of psychedelic-assisted therapy. Journal of Psychoactive Drugs, 52(4), 289– 299.

Mental Health America (2021). The 2021 state of mental health America. https://mhanational.org/issues/state-mental-health-america

Merikanas KR, He J, Rapoport J, Vitiello B, Olfson M. (2013) Medication use in US youth with mental disorders. Journal of the American Medical Association Pediatric. 167(2):141– 148.

Mion G. (2017). History of anesthesia: the ketamine story - past, present, and future. European Journal of Anesthesiology, 34, 571–575

Mithoefer MC. (2013) A Manual for MDMA-Assisted Psychotherapy in the Treatment of Post traumatic stress disorder. Santa Cruz, Calif, Multidisciplinary Association for Psychedelic Studies (MAPS)

Mithoefer MC, Wagner MT, Mithoefer AT, et al. (2011) The safety and efficacy of +/23, methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant post- traumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25, 439–452

Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Doblin, R. (2019). MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Journal of Psychopharmacology, 236, 2735–2745.

Multidisciplinary Association for Psychedelic Studies (2004) Rites of passage: Kids and psychedelics. MAPS, XIV(2). 4-8, 47-52.

National Institute on Aging (2021). What are clinical trials and studies? U.S. Department of Health and Human Services. National Institute of Health. Retrieved from: https://www.nia.nih.gov/health/what-are-clinical-trials-and-studies#four

Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355.

Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, … Schmidt BL 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology 30: 1165–1180 18

Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Work Group on Biomarkers and Novel Treatments, a Division of the American

Psychiatric Association Council of Research. (2020). Psychedelic and psychedelic assisted psychotherapy. American Journal of Psychiatry, 177(5), 391–410.

Schenberg, E. E. (2018). Psychedelic-assisted psychotherapy: A paradigm shift in psychiatric research and development. Frontiers in Pharmacology, 9, 733.

Song, S. Y., Miranda, A. H., Radliff, K. M., & Shriberg, D. (2019). School psychology in a global society: Roles and functions. NASP Publications.

Staff, T. P.-F. C. (2020, November 6). The cost of exclusion in psychedelic research. Bill of Health. Retrieved September 12, 2021, from https://blog.petrieflom.law.harvard.edu/2020/11/06/exclusion-psychedelic-research-diversity/.  

Stieg, C. (2021, July 24). Psychedelic trips could soon be part of therapy - here's what those sessions will look like. CNBC. Retrieved September 9, 2021, from https://www.cnbc.com/2021/07/24/how-psychedelic-assisted-therapy-with-mdma-and- psilocybin-works.html

U.S. Department of Veterans Affairs (2021). How common is PTSD in children and teens? PTSD: National Center for PTSD. https://www.ptsd.va.gov/understand/common/common_children_teens.asp  

Williams, M. T. (2018, March 20). Ethnic and racial identity and the therapeutic alliance. Psychology Today. Retrieved September 12, 2021, from https://www.psychologytoday.com/us/blog/culturally-speaking/201803/ethnic-and-racial-identity-and-the-therapeutic-alliance.

Williams, M. T., Reed, S., & George, J. (2020, September 8). Culture and psychedelic psychotherapy: Ethnic and racial themes from three black women therapists. AK Journals. Retrieved September 9, 2021, from https://akjournals.com/view/journals/2054/aop/article-10.1556-2054.2020.00137/article-10.15562054.2020.00137.xml.